Preterm mortality and morbidity over 25 years

被引:30
作者
Cooke, R. W. I. [1 ]
机构
[1] Univ Liverpool, Liverpool Womens Hosp, Neonatol Unit, Sch Reprod & Dev Med, Liverpool L8 7SS, Merseyside, England
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 2006年 / 91卷 / 04期
关键词
D O I
10.1136/adc.2005.080192
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Changing preterm population variables have masked improvements in neonatal survival over time. Increased use of antenatal steroids, caesarean section, and surfactant may have reduced the likelihood of mortality and periventricular haemorrhage by a third and doubled that of chronic lung disease, persistent duct, and septicaemia.
引用
收藏
页码:F293 / F294
页数:2
相关论文
共 5 条
[1]   Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial [J].
Ainsworth, SB ;
Beresford, MW ;
Milligan, DWA ;
Shaw, NJ ;
Matthews, JNS ;
Fenton, AC ;
Platt, MPW .
LANCET, 2000, 355 (9213) :1387-1392
[2]   The EPICure study: Outcomes to discharge from hospital for infants born at the threshold of viability [J].
Costeloe, K ;
Hennessy, E ;
Gibson, AT ;
Marlow, N ;
Wilkinson, AR .
PEDIATRICS, 2000, 106 (04) :659-671
[3]  
Crowley P, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000065
[4]  
Milner AD, 1996, TURKISH J PEDIATR, V38, P37
[5]  
Soll RF., 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000510, 10.1002/14651858.CD000510]